Table 1. Demographic characteristics of GR cohort.
| Patients | N=199 |
|---|---|
| Age, years | |
| Mean ± SD | 64.52±10.9 |
| Median [range] | 65 [28–86] |
| Gender, n (%) | |
| Male | 122 (61.3) |
| Female | 77 (38.7) |
| Performance Status at baseline CTC run (ECOG), n (%) | |
| 0 | 36 (18.1) |
| 1 | 97 (48.7) |
| 2 | 25 (12.6) |
| 3 | 10 (5.0) |
| 4 | 3 (1.5) |
| Not specified | 28 (14.1) |
| Stage, n (%) | |
| Stage IIIb | 6 (3.0) |
| Stage IV | 146 (73.3) |
| Not specified | 47 (23.6) |
| NSCLC histology, n (%) | |
| Adenocarcinoma | 174 (87.4) |
| Squamous | 16 (8.0) |
| Other | 7 (3.6) |
| Not determined | 2 (1.0) |
| Smoking status, n (%) | |
| Never | 37 (18.6) |
| Ex | 71 (35.7) |
| Current | 40 (20.1) |
| Not specified | 51 (25.6) |
The table shows the number (2nd column) and percentage (between round brackets) of patients having specific clinical pathological characteristics.